ICUconnect for Palliative Care in Older Adults
(ICUconnect 2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a mobile app called ICUconnect, designed to improve palliative care for older adults in the ICU. The app enables patients and their families to report care needs and assists ICU staff in delivering consistent, personalized care. The trial compares the effects of using ICUconnect with regular ICU care on outcomes such as reducing stress for patients and families. Suitable participants have family members in the ICU on a ventilator for at least two days and feel their palliative care needs are unmet. As an unphased trial, this study offers a chance to contribute to innovative care solutions that could enhance palliative care experiences for many families.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications. It is best to consult with the trial coordinators or your healthcare provider for guidance.
What prior data suggests that ICUconnect is safe for use in palliative care for older adults?
Research has shown that the ICUconnect app assists with palliative care needs in Intensive Care Units (ICUs). This digital tool organizes care by sending automated messages and emails.
Regarding safety, specific data on side effects is not available because ICUconnect is not a drug or medical procedure. It functions as a communication tool on devices like smartphones and tablets, eliminating concerns about the usual side effects associated with medications or surgeries.
The app aims to improve communication between families and ICU staff, making care more personalized and consistent. It is generally well-received, as it enhances how care is delivered without altering medical treatments.12345Why are researchers excited about this trial?
Unlike traditional palliative care in ICUs, which often relies on face-to-face meetings and manual communication, ICUconnect is unique because it uses a web app platform to streamline and automate communication between family members and clinicians. It delivers timed text messages and emails to guide families and medical staff through crucial tasks like surveys and coaching features over a 7- to 10-day period. Researchers are excited about ICUconnect because it promises to enhance person-centered care by ensuring consistent and structured communication, potentially improving the overall experience for families and patients during a critical time.
What evidence suggests that ICUconnect is effective for improving palliative care in older adults?
Studies have shown that ICUconnect, the intervention being tested in this trial, better meets the palliative care needs of older adults in the ICU compared to usual care. This mobile app enhances communication between families and doctors regarding patient needs. It sends timely messages and tasks to keep everyone informed and coordinated. Research indicates that ICUconnect helps ensure patients' palliative care needs are met, reducing stress for families. Overall, this tool is designed to ensure patients receive the right support at the right time in the ICU.23567
Who Is on the Research Team?
Christopher Cox, MD, MHA, MPH
Principal Investigator
Duke
Are You a Good Fit for This Trial?
This trial is for older adults with critical illnesses in ICUs and their caregivers. Participants must have high levels of unmet palliative care needs. The study excludes those who don't meet the specific inclusion criteria set by the researchers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the ICUconnect app for palliative care needs assessment and communication over a 7- to 10-day period
Follow-up
Participants are monitored for outcomes such as anxiety, depression, and PTSD symptoms
What Are the Treatments Tested in This Trial?
Interventions
- ICUconnect
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator